TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 311 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q4 2020. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $209,783 | -7.0% | 13,561 | -5.5% | 0.01% | +25.0% |
| Q2 2023 | $225,507 | -12.6% | 14,354 | -8.3% | 0.00% | 0.0% |
| Q1 2023 | $258,033 | +18.7% | 15,657 | +12.3% | 0.00% | +33.3% |
| Q4 2022 | $217,463 | +44.0% | 13,940 | +20.1% | 0.00% | +50.0% |
| Q3 2022 | $151,000 | -83.2% | 11,605 | -78.9% | 0.00% | -83.3% |
| Q3 2021 | $900,000 | +30.8% | 54,985 | +34.6% | 0.01% | +33.3% |
| Q2 2021 | $688,000 | +130.1% | 40,846 | +150.2% | 0.01% | +125.0% |
| Q1 2021 | $299,000 | +23.0% | 16,323 | +22.4% | 0.00% | 0.0% |
| Q4 2020 | $243,000 | – | 13,338 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bartlett & Co. LLC | 20,781 | $296 | 0.01% |
| Valued Wealth Advisors LLC | 231 | $3,574 | 0.00% |
| BALDWIN BROTHERS LLC/MA | 2,035 | $29,039 | 0.00% |